Discover MenaQ7®: the ONLY Vitamin K2 as MK-7 Proven to Support Cardiovascular Health

Share this article:


MenaQ7® Vitamin K2 as MK-7 is derived by natural fermentation, completely free from known allergens, backed by published studies demonstrating improvements in bone and cardiovascular health, enabling strong product positioning and differentiation.

  • Enable your product to stand out on crowded shelves with quality, branded ingredients.
  • Enjoy the confidence of making science-based claims based on MenaQ7® K2’s proven benefits.
  • Earn Consumer appreciation and loyalty – “Proof That It Works” is the No. 1 consumer selection criteria!

Adequate Vitamin K2 intake has been shown to positively influence the cardiovascular system, yet populations are deficient in this vital nutrient due to diet and commonly prescribed medications. MenaQ7® is the only Vitamin K2 as MK-7 shown in groundbreaking clinical studies to positively impact heart health, leading to it being the only Vitamin K2 as MK-7 is patented for cardiovascular health.

MenaQ7® Vitamin K2 Boosting Heart-Smart Formulations

MenaQ7® Vitamin K2 + Omega3 is a Dynamic Duo for Healthy Aging


Maintaining the best possible cardiovascular and bone health is key to overall health and well-being. Combining these two complementary and synergistic nutrients is an ideal formulation for the healthy aging category. Omega-3 is well recognized as a cardio-support nutrient with qualified health claims in the US and four EFSA claims, but it is missing the ability to impact vascular calcification. Growing research documents Vitamin K2’s protective effect on cardiovascular health through the activation of matrix Gla protein, the most potent inhibitor of vascular calcification known. MenaQ7® Vitamin K2 completes “heart-smart” formulations with its clinically proven cardiovascular health benefits, including maintaining and promoting arterial flexibility.


How MenaQ7® Vitamin K2 Supercharges Vitamin D3 for Heart Health


Matrix Gla Protein (MGP) is the most potent inhibitor of vascular calcification known to date, but it requires Vitamin D to be synthesized. However, MGP is also a K-dependent protein, so it also needs Vitamin K2 to become active, enabling it to actively stop calcium from depositing in the vasculature and other soft tissues.


The combination of MenaQ7® Vitamin K2 and D3 is clinically proven to have cardiovascular benefits, compared to vitamin D3 alone, and confirms their synergistic effect on cardiovascular health.


Deficiency or suboptimal levels of K2 may result in inactive MGP, which is associated with soft tissue calcification. Other features where vitamin D and K overlap in creating synergies for health are their ability to regulate inflammation and oxidative stress markers and may therefore support the immune system.

101 rue de Menin
59700 Marcq-en-Baroeul

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox twice a month.

The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs.